NCT07034859 2025-06-24
Cabergoline in the Management of Nonfunctioning Pituitary Adenoma
National Taiwan University Hospital
Phase 4 Enrolling by invitation
Clinical Trials
6 trialsNCT01794793 2024-10-01
Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies
RECORDATI GROUP
Phase 4 Completed
NCT01915303 2020-09-18
Study of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's Disease
Novartis
Phase 2 Terminated
NCT03457389 2020-03-18
Comparison of Treatment Outcome of Cabergoline According to Target Prolactin Levels in Patients With Prolactinoma
Seoul National University Hospital
Phase NA Unknown
NCT03271918 2017-09-07
Cabergoline in Nonfunctioning Pituitary Adenomas
University of Sao Paulo General Hospital
Phase 3 Completed
NCT00376064 2017-03-06
Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly
Novartis
Phase 4 Completed